DRKS00028896
Completed
Not Applicable
Breast cancer risk after modern radiotherapy - CRAMER
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C81
- Sponsor
- Medizinische Hochschule Brandenburg Campus GmbH
- Enrollment
- 146
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Cancer diagnosed as of 2006 with upper body\-directed radiotherapy treatment using any technique derived from computer tomography\-based treatment planning, 2\. Hodgkin, other lymphoma and sarcoma patients have top priority for admission, patients with breast cancer, lung cancer or esophageal cancer with radiotherapy radiation to the breast may be included on an individual basis, 3\. all quadrants and the central area of ??both breasts can be delineated on the planning computer tomography are (or have previously been) delineated (according to the study plan below described procedure), 4\. the radiotherapy dose can be determined for all quadrants (and the central area) of both breasts, 5\. at least one of the breast quadrants / central areas is partially in the radiation field
Exclusion Criteria
- •1\. patients who have received posterior radiotherapy for sarcomas, 2\. patients who have received palliative radiotherapy, 3\. patients less than 15 years old at the time of cancer diagnosis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Consequences of radiation therapy in breast cancer in patients with breast implantC50Malignant neoplasm of breastDRKS00004334Klinik für Strahlenheilkunde60
Not yet recruiting
Phase 2
A study on the optimal sequencing of radiation In breast cancer(NEOORB)CTRI/2024/06/068847All India Institute of Medical Sciences, Jodhpur
Completed
Not Applicable
TOxicity After Radiotherapy in breAst CancEr Survivors (ThORACeS) - A Retrospective Cohort StudyBreast CancerNCT02471079University Medical Center Groningen706
Recruiting
Not Applicable
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast CancerBreast Cancer, Familial MaleRadiotherapy; ComplicationsChemotherapeutic ToxicityImmune Checkpoint InhibitorCDK4/6 InhibitorTrastuzumabPertuzumabPARP InhibitorNCT06197581Cancer Institute and Hospital, Chinese Academy of Medical Sciences148
Completed
Phase 3
Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.Breast CancerNCT00156806AHS Cancer Control Alberta231